1-6 of 6
Steven K. Davidsen
Close
Sort by
Journal Articles

Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML

Jianbiao Zhou, Chonglei Bi, Jasinghe V. Janakakumara, Shaw-Cheng Liu, Wee-Joo Chng, Kian-Ghee Tay, Lai-Fong Poon, Zhigang Xie, Senthilnathan Palaniyandi, Hanry Yu, Keith B. Glaser, Daniel H. Albert, Steven K. Davidsen, Chien-Shing Chen
Journal: Blood
Blood (2009) 113 (17): 4052–4062.
https://doi.org/10.1182/blood-2008-05-156422
Published: 2009
Includes: Supplemental data
Journal Articles

Identification of Core Gene Signature Associated with Synergism Between ABT-869, a FLT3 Inhibitor and SAHA, a HDAC Inhibitor in AML with FLT3-ITD Mutation.

Jianbiao Zhou, MD, MS, Chonglei Bi, Bsc, Shaw-Cheng Liu, Wee-Joo Chng, MD, Kian-Ghee Tay, Bsc, Hanry Yu, Ph.D., Keith Glaser, Ph.D., Daniel Albert, PhD, BSc, Steven K Davidsen, Ph.D., Chien-Shing Chen, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1618.
https://doi.org/10.1182/blood.V112.11.1618.1618
Published: 2008
Journal Articles

Multi-Targeted Receptor Tyrosine Kinase Inhibitor, ABT-869, Induces Apoptosis and Inhibition of Proliferation of Ba/F3 FLT-3 ITD Mutant Cells.

Jenny E. Hernandez, BS, Junling Li, Ru-Qi Wei, Paul Tapang, Steven K. Davidsen, PhD, Daniel H. Albert, PhD, Patrick A. Marcotte, PhD, Keith B. Glaser, PhD, Cecilia Fu, M.D., Kathleen M. Sakamoto, M.D. PhD.
Journal: Blood
Blood (2007) 110 (11): 1589.
https://doi.org/10.1182/blood.V110.11.1589.1589
Published: 2007
Journal Articles

Targeting FLT3 Phosphorylation and Signaling in Acute Myeloid Leukemia.

Alan K. Ikeda, MD, Dejah Judelson, Junling Li, Ru Qi Wei, Paul Tapang, Steven K. Davidsen, Ph.D., Dan H. Albert, Ph.D., Keith B. Glaser, Ph.D., Cecilia Fu, M.D., Kathleen M. Sakamoto, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 912.
https://doi.org/10.1182/blood.V110.11.912.912
Published: 2007
Journal Articles

ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia

Deepa B. Shankar, Junling Li, Paul Tapang, J. Owen McCall, Lori J. Pease, Yujia Dai, Ru-Qi Wei, Daniel H. Albert, Jennifer J. Bouska, Donald J. Osterling, Jun Guo, Patrick A. Marcotte, Eric F. Johnson, Niru Soni, Kresna Hartandi, Michael R. Michaelides, Steven K. Davidsen, Saul J. Priceman, Jenny C. Chang, Katrin Rhodes, Neil Shah, Theodore B. Moore, Kathleen M. Sakamoto, Keith B. Glaser
Journal: Blood
Blood (2007) 109 (8): 3400–3408.
https://doi.org/10.1182/blood-2006-06-029579
Published: 2007
Includes: Supplemental data
Journal Articles

The Multi-Targeted Receptor Tyrosine Kinase Inhibitor, ABT-869, Induces Apoptosis of AML Cells Both In Vitro and In Vivo.

Deepa B. Shankar, PhD, Jenny C. Chang, Bertrand Parcells, Salemiz Sandoval, Junling Li, Ru-Qi Wei, Paul Tapang, Steven K. Davidsen, PhD, Dan H. Albert, PhD, Keith B. Glaser, PhD, Theodore B. Moore, MD, Kathleen M. Sakamoto, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 616.
https://doi.org/10.1182/blood.V106.11.616.616
Published: 2005